【活動訊息】12/4_SPARK-BIH National GCT Webinar Series 2025
Designing the Future of Clinical Trials in Cell and Gene Therapy
The SPARK-BIH National Gene and Cell Therapy Program proudly presents the 9th session of its expert-led webinar series, exploring how clinical trial design is evolving to address the unique challenges of cell and gene therapy (CGT) development. This session will discuss innovative frameworks, patient stratification, regulatory perspectives, and practical strategies shaping the next generation of CGT trials.
Prof. Fiona Thistlethwaite, Medical Oncology Consultant at The Christie NHS Foundation Trust, Co-Director of the NIHR Manchester Clinical Research Facility, and Director of the Innovate Manchester Advanced Therapy Centre Hub (iMATCH), will share her extensive experience in experimental cancer medicine and the responsible translation of novel immunotherapies into clinical practice.
Event Details:
Date: 4 December 2025 (Thursday)
Time: 15:30 - 16:30 CET | 10:30 PM CST ( Taiwan Time )
Location: Online via MS Teams
Speaker:
Prof. Fiona Thistlethwaite
Medical Oncology Consultant, The Christie NHS Foundation Trust
Co-Director, NIHR Manchester Clinical Research Facility
Director, Innovate Manchester Advanced Therapy Centre Hub (iMATCH)
What You Will Learn:
- Why clinical trial design for cell and gene therapies requires new frameworks
- Impact of genetically defined patient groups on endpoints and biomarkers
- Strategies for early-phase study design and dose selection
- How to responsibly translate preclinical data into clinical plans
- Regulatory considerations shaping CGT development today
Online via MS Teams | Registration Required
Click here to register
Registration required by 2 December 2025. You will receive the MS Teams link and access code the evening before the event. Please note that late registrations may not be guaranteed access.